Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-04-15 Syntone Ventures LLC 10% owner Purchase +714,286 1,705,438
2024-04-15 Syntone Ventures LLC 10% owner Purchase · Warrant (Right to Buy) +1,071,429 1,071,429
2021-02-03 Syntone Ventures LLC 10% owner Purchase +3,000,000 $1.00 $3.0M 19,823,045
2020-07-15 Syntone Ventures LLC 10% owner Purchase +823,045 $1.22 $1000K 16,823,045

Page 1 of 1 · 4 trades